Literature DB >> 790414

Monitoring plasma concentrations of neuroleptics.

M Lader.   

Abstract

Among the neuroleptics chlorpromazine has been the most extensively studied despite its complex metabolic pathways. Several metabolites, in particular 7-hydroxychlorpromazine, are psychotropically active. Oral phenothiazines are extensively metabolised "first-pass" through the liver. The relationship between clinical response and plasma concentrations of neuroleptics is tenous. The reasons for the lack of correlation include spontaneous remission in some patients, problems with flexible dosage schedules, the type of patient studied, differences in metabolic patterns, induction of metabolism in the liver, interactions with other drugs, and variations in plasma protein binding. Alternative research strategies might be to study metabolically less complex drugs such as haloperidol or to relate clinical response to autonomic, extrapyramidal, EEG, biochemical or endocrine measures.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 790414     DOI: 10.1055/s-0028-1094491

Source DB:  PubMed          Journal:  Pharmakopsychiatr Neuropsychopharmakol        ISSN: 0031-7098


  9 in total

1.  Neuroleptic blood levels and therapeutic effect.

Authors:  B M Cohen; J F Lipinski; H G Pope; P Q Harris; R I Altesman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 2.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 3.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

4.  Binding affinity of levomepromazine and two of its major metabolites of central dopamine and alpha-adrenergic receptors in the rat.

Authors:  S G Dahl; H Hall
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Interaction of chlorpromazine with tea and coffee.

Authors:  H J Cheeseman; M J Neal
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

Review 6.  Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia.

Authors:  M F Bristow; S R Hirsch
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

7.  Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man.

Authors:  G Taylor; J B Houston; J Shaffer; G Mawer
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

8.  Fluphenazine pharmacokinetics and therapeutic response.

Authors:  M W Dysken; J I Javaid; S S Chang; C Schaffer; A Shahid; J M Davis
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  One-compartment model with Michaelis-Menten elimination kinetics and therapeutic window: an analytical approach.

Authors:  Sanyi Tang; Yanni Xiao
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-09-15       Impact factor: 2.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.